(Q34984119)

5 August 2017

1 reference

title

Therapy of acute hepatitis C. (English)

1 reference

5 August 2017

Alfredo Alberti

1

1 reference

5 August 2017

Silvia Boccato

series ordinal

2

1 reference

5 August 2017

Alessandro Vario

series ordinal

3

1 reference

5 August 2017

Luisa Benvegnù

series ordinal

4

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

5 August 2017

1 reference

5 August 2017

36

1 reference

5 August 2017

5 Suppl 1

1 reference

5 August 2017

S195-200

1 reference

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

5 August 2017

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36808

Hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36808

The natural history of hepatitis C virus infection: host, viral, and environmental factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36808

Natural history of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36808

A randomized controlled trial of recombinant interferon alpha-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36808

Effects of interferon beta on non-A, non-B acute hepatitis: a prospective, randomized, controlled-dose study. Japan Acute Hepatitis Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36808

Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36808

Interferon therapy in haemodialysis patients with acute hepatitis C virus infection and factors that predict response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36808

High-dose interferon-alpha2b treatment prevents chronicity in acute hepatitis C: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36808

Treatment of acute hepatitis C with interferon alfa-2b

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36808

Hepatitis C virus viremia following clinical resolution of acute hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36808

Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36808

Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36808

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36808

Interferon-alpha in acute posttransfusion hepatitis C: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36808

Resolution of acute hepatitis C after therapy with natural beta interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36808

The treatment of acute post-transfusion hepatitis C with recombinant interferon-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36808

Therapy for acute hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36808

21 January 2018

Identifiers

DOI

10.1053/JHEP.2002.36808

1 reference

5 August 2017

1 reference